NeoImmuneTech, Inc. (KOSDAQ:A950220) announced that it has received $4,700,000 in funding led by Kindstar Global (Beijing) Technology, Inc. on November 25, 2021. The transaction included participation from Hefei SPARK Venture Capital Management Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 HKD | +3.08% | +3.18% | -3.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.57% | 197M | |
-22.13% | 7.9B | |
+76.16% | 4.53B | |
+8.56% | 2.78B | |
-2.80% | 2.64B | |
-50.41% | 1.99B | |
-19.59% | 1.66B | |
-20.07% | 1.49B | |
+19.31% | 1.23B | |
-45.78% | 1.1B |
- Stock Market
- Equities
- 9960 Stock
- News Kindstar Globalgene Technology, Inc.
- NeoImmuneTech, Inc. announced that it has received $4.7 million in funding from Hefei SPARK Venture Capital Management Co., Ltd., Kindstar Global Technology, Inc.